Cargando…

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan

Rising prices of novel cancer medications are increasing the economic burden from cancer in Jordan, risking the ability of cancer patients to access lifesaving and life-extending treatments. Furthermore, in the absence of a national health technology assessment (HTA) framework, medication prices in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treish, Imad, Al Rabayah, Abeer, Jaddoua, Saad, Tuffaha, Haitham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863990/ https://www.ncbi.nlm.nih.gov/pubmed/34773599 http://dx.doi.org/10.1007/s41669-021-00293-4

Ejemplares similares

Oncology pharmacists’ response to COVID-19 pandemic in Jordan: The King Hussein Cancer Center experience
por: Al-Rabayah, Abeer A, et al.
Publicado: (2021)

Will Jordan be closer to UHC after the COVID-19 pandemic?
por: Al-Ajlouni, Reem, et al.
Publicado: (2020)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process
por: Li, Fang, et al.
Publicado: (2022)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022)

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
por: Sendi, Pedram
Publicado: (2020)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

Cost-Effectiveness Analysis and the Formulary Decision-Making Process
por: Wang, Zhixiao, et al.
Publicado: (2004)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
por: Jit, Mark, et al.
Publicado: (2012)

Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making
por: Chen, Shuxian, et al.
Publicado: (2021)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
por: Gidwani, Risha, et al.
Publicado: (2020)

Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
por: Kent, Seamus, et al.
Publicado: (2019)

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency
por: Shields, Gemma E., et al.
Publicado: (2021)

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States
por: Carlson, Josh J., et al.
Publicado: (2019)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
por: Elbasha, Elamin H.
Publicado: (2022)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan
por: Al Rabayah, Abeer Ahmad, et al.
Publicado: (2019)

Shared Decision Making in a Youth Mental Health Service Design and Research Project: Insights From the Pan-Canadian ACCESS Open Minds Network
por: Guinaudie, Chloé, et al.
Publicado: (2020)

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario
por: Duarte, Flavia A., et al.
Publicado: (2022)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013)

The Implementation of a Multidisciplinary Lactation Program and the Subsequent Influence of Coronavirus Disease 2019: Observations of One Large Neonatal Intensive Care Unit
por: Sanchez, Janelle, et al.
Publicado: (2023)

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
por: Seo, Mikyung Kelly, et al.
Publicado: (2021)

Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vr5me16a3dtj23kprlfdsj68r2